KeyZell boosts its cancer treatments

Receive an award for an Artificial Intelligence development. 

KeyZell promotes its cancer treatments and for this it has received an award in the II Edition of the Isaac Peral National Research, Science and Innovation Awards organized by the European Association of Economy and Competitiveness for the development of Artificial Intelligence.

These awards recognize the research work carried out by the biotech startup in the development of Artificial Intelligence capable of recommending personalized treatments for lung and breast cancer to medical professionals .

More informationKeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool

KeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool

This “startup” is distinguished by attacking cancer from two fronts, research into first-line cancer treatments and the use of AI technology for precision medicine in oncology (Oncology Precision System).

The awards also recognized the work of professionals such as Dr. Elisabeth Arrojo Álvarez, Medical Director of the Medical Institute of Advanced Oncology (Inmoa) , who was distinguished for her professional research career in the oncology world, highlighting the development of a pioneering technique in breast cancer that shortens the number of radiotherapy sessions from more than 30 daily sessions to a single session.

The European Association of Economy and Competitiveness awards the merit of researchers who carry out outstanding work in scientific fields and who contribute to the advancement of science, better knowledge of the human being, technology transfer and the progress of humanity.

Likewise, it distinguishes those entities that have made innovation an indispensable element in business development and growth, demonstrating a powerful lever for innovation and competitiveness.

Backed by an internationally renowned management and research team, KeyZell helps oncologists make more accurate decisions by enabling personalized medicine, reducing recurrence, overmedication, hospitalization time, treatment costs, follow-up through of all clinical phases, and, above all, it has a positive impact on the quality of life of patients.

Token issuance

In addition, it is preparing a Token Generation Event (TGE) with an issuance of 2 billion tokens and 200,000 NFTs.

This token issue is a risk-free investment despite the current destabilization of the crypto market, since it is backed by the company’s own value, meaning that this investment is not merely speculative and does not depend on market value.

With this issue, KeyZell intends to continue advancing in its project to fight cancer and operate in a secure environment, since they work under “blockchain” technology.

See here the complete article of Diario de Sevilla.

Dr Nabil Hajji

Dr Nabil Hajji

World-renowned expert in the field of oncology, recognized for establishing the mechanism underlying the resistance of classical antitumor treatments in various types of cancer, related to the epigenetic mechanism that controls apoptosis and the tumor microenvironment.

Dr Nabil Hajji

Dr Nabil Hajji

World-renowned expert in the field of oncology, recognized for establishing the mechanism underlying the resistance of classical antitumor treatments in various types of cancer, related to the epigenetic mechanism that controls apoptosis and the tumor microenvironment.

Recent news

Follow us on the networks

Subscribe to our newsletters

You will only receive notifications about new news and updates.

More news

KeyZell awarded with the Andalucía Excelente prize, best Biotechnology company 2022.

KeyZell received the Andalucía Excelente Award as the best Biotechnology company 2022. KeyZell, awarded for its commitment to create a new future for oncology, through …

Read more →

Fourier Intelligence, iRhythm and KeyZell are the most internationally recognized companies for revolutionizing the health sector

Health Tech World has released a compilation of the top 50 health technology innovators of 2022 who stand out for their unique innovation, outstanding technology …

Read more →

KeyZell has been awarded as the “Most Pioneering Biotechnology Company – Europe”

KeyZell has been awarded as the “Most Pioneering Biotechnology Company – Europe” in the seventh edition of the “International Life Sciences Awards 2022“. This event …

Read more →

KeyZell continues to advance in the development of its Artificial Intelligence tool

The biotech startup KeyZell has officially announced the launch of its exclusive fungible token useful to receive the service of its Artificial Intelligence system for precision medicine …

Read more →

Revealed: The Health Tech World Top 50 Innovators of 2022

Health Tech World has announced its Top 50 health tech innovators of 2022. Here are the top picks of health tech companies who stand out …

Read more →

The capital dresses up for science

The European Association of Economy and Competitiveness celebrates the second edition of the Isaac Peral National Award for Research, Science and Innovation The investigation was …

Read more →

Artificial intelligence: key to optimizing clinical decisions in cancer patients

“The OPS (Oncology Precision System) starts from the genetic characteristics of each patient and is capable of proposing the best combination of treatments currently available …

Read more →

KeyZell Awarded for Treating Cancer with Biotechnology, Artificial Intelligence

06.28.2022 2:48 pm Biotechnological startup Keisel has been honored at the second edition of the Isaac Perel National Research, Science and Innovation Awards organized by …

Read more →

KeyZell revolutionizes the fight against lung and breast cancer with an Artificial Intelligence tool

The Spanish biotechnology startup KeyZell, in alliance with the technology company Iakan, has presented an Artificial Intelligence solution capable of recommending personalized treatments for lung …

Read more →